<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
	<head>
		<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
		<title>ProteoTech Inc. &mdash; Our Technologies: Alzheimer's (Small molecule Approach)</title>
		<meta name="Description" content="Small molecule approach to treating Alzheimer's disease" />
		<meta name="Keywords" content="small molecule, Alzheimer's disease, beta amyloid protein, amyloid plaque, Exebryl-1, FDA, Human Phase I Clinical Trails, helical filament, neurofibrillary tangle formation, bioavailability, International Alzheimer's Conference, Alzheimer's cascade hypothesis" />
		<meta name="Language" content="English" />
		<meta name="Robots" content="All" />
		<link href="/css/styles.css" rel="stylesheet" type="text/css" media="screen" />
		<link href="/css/print.css" rel="stylesheet" type="text/css" media="print" />
		<!--[if lte IE 6]>
			<link href="/css/lteie6.css" rel="stylesheet" type="text/css" media="screen" />
		<![endif]-->
		<style type="text/css">
			.style2 {	font-size: 8pt;}
			.style3 {font-size: 8pt; font-style: italic; }
		</style>
		<script type="text/javascript" src="/js/p7popmenu-packed.js"></script>
		<script type="text/javascript" src="/js/SpryEffects-packed.js"></script>
		<script type="text/javascript" src="/js/p7vscscripts.js"></script>
		<script type="text/javascript">
			<!--
			function MM_effectAppearFade(targetElement, duration, from, to, toggle) {
				Spry.Effect.DoFade(targetElement, {duration: duration, from: from, to: to, toggle: toggle});
			}
			//-->
		</script>
	</head>
	<body onload="P7_initPM(1,0,1,-20,10)">
		<div id="wrapper">
			<div class="contactAppear" id="contactAppear">
				<p><strong><img src="images/logo.gif" width="219" height="57" align="right" class="logo" /></strong></p>
				<p>
					<strong>ProteoTech, Inc</strong>. <br />
					12040 115th Ave., NE<br />
					Kirkland, WAÂ 98034
				</p>
				<p>
					<strong>Office:</strong> (425) 823-0400<br />
					<strong>Fax: </strong>(425) 823-8508<br />
					<strong>E-mail: </strong> <a href="mailto:info@proteotech.com">info@proteotech.com</a>
				</p>
				<p align="right" class="close"><a href="#" onclick="MM_effectAppearFade('contactAppear', 800, 100, 0, false)">Close Window</a></p>
			</div>
			<div id="logoBand">
				<h1 class="logoBox">
					<a href="../index.html" title="ProteoTech, World Leader in Therapeutics and Diagnostics Targeting Amyloid Diseases">
						<img src="../images/logo.gif" alt="" width="219" height="57" border="0" alt="ProteoTech, Inc" />
					</a>
				</h1>
				<div class="taglineBox">
					<h2>A World Leader in Therapeutics Targeting Misfolded Proteins and Amyloid Diseases</h2>
				</div>
			</div>
			<div id="photoBand">
				<div class="mainPhotoBox"><img src="../images/home_photo_temp.gif" width="680" height="205" /></div>
				<div class="sidebarPhotoBox"><img src="../images/about_sidebar_new.jpg" width="214" height="205" /></div>
			</div>
			<div id="contentBox">
				<div id="navBox">
					<ul id="p7PMnav">
						<li><a href="/" title="ProteoTech Home">Home</a></li>
						<li><a href="/about/mission.html" title="About ProteoTech, Inc" class="p7PMtrg">About Us</a>
							<ul>
								<li><a href="/about/mission.html" title="Our Mission">Our Mission</a></li>
								<li><a href="/about/history.html" title="Our History">Our History</a></li>
								<li><a href="/about/targets.html" title="Targeted Markets">Targeted Markets</a></li>
								<li><a href="/about/intellectual.html" title="Intellectual Property">Intellectual Property</a></li>
								<li><a href="/about/leadership_team.html" title="ProteoTech's Leadership Team">Leadership Team</a></li>
							</ul>
						</li>
						<li><a href="/technologies/proteoglycan.html" title="ProteoTech's Technologies" class="p7PMtrg">Our Technologies</a>
							<ul>
								<li><a href="/technologies/proteoglycan.html" title="Amyloid &amp; Proteoglycan Technologies">Amyloid &amp; Proteoglycan Technologies</a></li>
								<li><a href="/technologies/therapeutic_approach.html" title="Therapeutic Approach">Therapeutic Approach</a></li>
								<li><a href="/technologies/alzheimers_small.html" title="Alzheimer's Small Molecule">Alzheimer's - Small Molecule</a></li>
								<li><a href="/technologies/alzheimers_peptide.html" title="Alzheimer's Peptide">Alzheimer's - Peptide</a></li>
								<li><a href="/technologies/parkinsons.html" title="Parkinson's Small Molecule">Parkinson's - Small Molecule</a></li>
								<li><a href="/technologies/systemic.html" title="AL Amyloidosis - Small Molecule">AL Amyloidosis - Small Molecule</a></li>
							</ul>
						</li>
						<li><a href="/pipeline/pipeline_overview.html" title="Pipeline" class="p7PMtrg">Pipeline</a>
							<ul>
								<li><a href="/pipeline/pipeline_overview.html" title="Pipeline Overview">Overview</a></li>
								<li><a href="/pipeline/exebryl.html" title="Exebryl-1"><strong>Exebryl-1<sup>&reg;</sup></strong></a></li>
								<li><a href="/pipeline/pepticlere.html" title="PeptiClere">PeptiClere<sup>&trade;</sup></a></li>
								<li><a href="/pipeline/synuclere.html" title="Synuclere">Synuclere<sup>&trade;</sup></a></li>
								<li><a href="/pipeline/systebryl.html" title="Systebryl">Systebryl<sup>&trade;</sup></a></li>
							</ul>
						</li>
						<li><a href="/news/news_press.html" title="ProteoTech News and Publications" class="p7PMtrg">News/Publications</a>
							<ul>
								<li><a href="/news/news_press.html" title="News/Press Releases">News / Press Releases</a></li>
								<li><a href="/news/scientific_pubs.html" title="Scientific Publications">Scientific Publications</a></li>
							</ul>
						</li>
						<li><a href="/contact.shtml" title="Contact ProteoTech">Contact Us</a></li>
						<!--[if lte IE 6]><style>#p7PMnav a{height:1em;}#p7PMnav li{height:1em;}#p7PMnav ul li{float:left;clear:both;width:100%}</style><![endif]-->
						<!--[if IE 6]><style>#p7PMnav ul li{clear:none;}</style><![endif]-->
						<!--[if IE 7]><style>#p7PMnav a{zoom:100%;}#p7PMnav ul li{float:left;clear:both;width:100%;}</style><![endif]-->
					</ul>
				</div>
				<table width="895" border="0" cellspacing="0" cellpadding="0">
				<tr class="curvy"><td><img src="../images/curves_top.gif" alt="Proteotech" width="895" height="16"/></td></tr>
					<tr>
						<td class="BG_content_fill">
							<div id="column1">
								<h3 align="center"><strong>SMALL MOLECULE APPROACH TO TREATING ALZHEIMER'S DISEASE</strong></h3>
								<p>ProteoTech is one of a few companies at the forefront of developing disease-modifying small molecule compounds targeted at inhibiting the formation and aggregation of a toxic substance found in patients with Alzheimer's disease known as beta-amyloid protein deposits.</p>
								<p>Beta-amyloid protein deposits and amyloid plaques occur normally within all aging brains. But, unlike the normal aging brain, Alzheimer's disease brains form and accumulate amyloid deposits and plaques at a much greater rate and densities, thereby leading to a cascade effect that over time, results in the death of healthy brain cells and patient memory loss.</p>
								<p>ProteoTech's innovative small molecule, <strong>Exebryl-1<sup>&reg;</sup></strong>, is currently being tested for safety in FDA authorized Human Phase I Clinical Trials. <strong>Exebryl-1<sup>&reg;</sup></strong> has shown in laboratory research to interfere with the formation of toxic beta-amyloid deposits and fibrils which are believed by medical professionals and researchers to be a key component in the progression of Alzheimer's disease.</p>
								<p><strong>Initial studies suggest that <strong>Exebryl-1<sup>&reg;</sup></strong></strong> may also have an important dual capacity by inhibiting and reducing tau protein from forming paired helical filaments, important in neurofibrillary tangle formation. The presence of neurofibrillary tangles in brain containing tau protein is an important pathological hallmark of Alzheimer's disease. Further studies are ongoing to confirm these exciting findings.</p>
								<p><strong><strong>Exebryl-1<sup>&reg;</sup></strong> may be the first orally bioavailable small molecule drug that affects both amyloid plaque and neurofibrillary tangle accumulation</strong>, the two major characteristic and pathological lesions of Alzheimer's disease.</p>
								<table border="0" cellspacing="10" cellpadding="0">
									<tr>
										<td valign="top"><img src="../images/movie-clip.jpg" width="78" height="76" /></td>
										<td valign="top">
											<p>Alzheimer's disease Cascade Hypothesis - Formation of beta-amyloid protein deposits, plaques and tangles - resulting in memory loss</p>
											<ul class="specialButton">
												<li><a href="http://www.nia.nih.gov/Alzheimers/Publications/UnravelingTheMystery/">Play Movie</a></li>
											</ul>
											<span class="style3">Located at bottom of NIA page</span>
											<p class="style2">Originator: National Institute of Aging Source: <a href="http://www.nia.nih.gov" target="_blank">www.nia.nih.gov</a></p>
										</td>
										<td valign="top"><img src="../images/poster_exebryl.jpg" /></td>
										<td valign="top">
											<p class="style3">ProteoTech International Alzheimer's Conference Presentation - <strong>Exebryl-1<sup>&reg;</sup></strong></p>
											<div class="specialButton">
												<a href="../pdfs/exebryl-1_poster.pdf" target="_blank">Download Poster (PDF)</a>
											</div>
										</td>
									</tr>
								</table>
							</div>
							<div id="column2">
								<ul>
									<li><a href="../technologies/alzheimers_small.html">Alzheimer's disease</a></li>
									<li><a href="../technologies/parkinsons.html">Parkinson's disease</a></li>
									<li><a href="../technologies/systemic.html">Systemic AA disease</a></li>
									<li><a href="../news/scientific_pubs.html">Scientific Publications</a></li>
								</ul>
								<br />
								<br />
								<p><img src="../images/alz_disease.jpg" /></p>
								<br />
								<br />
								<p><a href="../images/amyl_plaque.jpg"><img src="../images/amyl_plaque.jpg" /></a></p>
								<br />
								<br />
								<p align="center"><img src="../images/alz_brain.gif" /><br /><br /></p>
								<br />
								<br />
								<div class="specialButtonLearn"><a href="../pipeline/exebryl.html"><img src="../images/learn_exebryl.jpg" width="180" height="51" border="0" /></a></div>
								<br />
								<br />
							</div>
						</td>
					</tr>
				<tr class="curvy"><td><img src="../images/curves_bottom.gif" alt="Proteotech" width="895" height="16" /></td></tr>
				</table>
			</div>
		</div>
		<div id="footerBox">
			<div id="footer">
				<p>Copyright &copy; 2012 ProteoTech, Inc.<br />425.823.0400&nbsp;&nbsp; <a href="mailto:info@proteotech.com">info@proteotech.com</a></p>
			</div>
		</div>
		<script type="text/javascript">
			var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");
			document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));
			var pageTracker = _gat._getTracker("UA-5988449-1");
			pageTracker._trackPageview();
		</script>
	</body>
</html>
